Caduet
Product Images NDC 54868-5209

18 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Caduet (NDC 54868-5209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Caudet (Caudet)

Image Of Caudet (Caudet)
Caduet tablet label showing the proprietary name with active ingredients amlodipine besylate and atorvastatin calcium. The label specifies strengths as 5mg, 10mg, and 10mg and indicates a count of 90 tablets. The labeler is Physicians Total Care, Inc.*
FDA Label Image

Image Of Figure 1 Graph (Figure 1 Graph)

Image Of Figure 1 Graph (Figure 1 Graph)
A Kaplan-Meier curve chart comparing event rates over time (months) between placebo and Amlodipine groups. The vertical axis shows event rate, and the horizontal axis shows time in months up to 24. The chart includes a P-value of 0.003, a hazard ratio of 0.691, and a 95% confidence interval (0.54, 0.88). Numbers at risk are displayed below the time axis.*
FDA Label Image

Image Of Figure 2 Chart (Figure 2 Chart)

Image Of Figure 2 Chart (Figure 2 Chart)
A forest plot displaying hazard ratios with 95% confidence intervals comparing Amlodipine versus Placebo. The plot includes stratified groups such as overall patients, age categories, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessels with stenosis, and PCI-stent strata. The horizontal axis represents hazard ratios ranging from 0.0 to 2.0 with a vertical line at 1.0 indicating no effect. A note states that mean baseline systolic blood pressure is 129 mmHg.*
FDA Label Image

Image Of Figure 3 Graph (Figure 3 Graph)

Image Of Figure 3 Graph (Figure 3 Graph)
A line graph depicting cumulative incidence (%) over 3.5 years comparing Atorvastatin to placebo. The graph shows lower incidence for Atorvastatin, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005, illustrating comparative effectiveness over time.*
FDA Label Image

Image Of Figure 4 Graph (Figure 4 Graph)

Image Of Figure 4 Graph (Figure 4 Graph)
A line graph depicting cumulative hazards over time (months) to the first primary endpoint through four years of follow-up. It compares two treatment groups: Atorvastatin, shown as a solid line, and placebo, shown as a dashed line. The graph includes a hazard ratio with 95% confidence interval indicating lower cumulative hazards for Atorvastatin compared to placebo.*
FDA Label Image

Image Of Figure 5 Graph (Figure 5 Graph)

Image Of Figure 5 Graph (Figure 5 Graph)
A Kaplan-Meier survival curve graph showing the time to first major cardiovascular endpoint over 5 years for two groups treated with Atorvastatin (80mg and 10mg). The graph plots the proportion of patients free from major cardiovascular events over time, with accompanying hazard ratio and p-value statistics indicating a significant difference between groups.*
FDA Label Image
FDA Label Image

Image Of Both Chemical Structures (Chemical Structures)

Image Of Both Chemical Structures (Chemical Structures)
Chemical structures of amlodipine besylate and atorvastatin calcium are shown side by side. The structures include molecular formula and detailed atom-bond representations for each active ingredient found in Caduet, labeled respectively.*
FDA Label Image

Image Of 2.5/20 mg Package Label (Package Label 01)

Image Of 2.5/20 mg Package Label (Package Label 01)
Label for Caduet 5/20 mg by Physicians Total Care, Inc., distributed in Tulsa, Oklahoma. The label includes the NDC 54868-5672-0, lot number 0000, and an expiration date of 01/60. It also states manufacturing by Pfizer Ireland Pharmaceuticals, Dublin, Ireland, and features a barcode with number 56720300000.*
FDA Label Image

Image Of 2.5/40 mg Package Label (Package Label 02)

Image Of 2.5/40 mg Package Label (Package Label 02)
Label for Caduet 5/40mg showing distributor Physicians Total Care, Inc. in Tulsa, OK, NDC 54868-5699-0. Includes lot number 0000, expiration date 01/60, and manufacturing by Pfizer Ireland Pharmaceuticals in Dublin, Ireland. A barcode is also present.*
FDA Label Image

Image Of 5/10 mg Package Label (Package Label 03)

Image Of 5/10 mg Package Label (Package Label 03)
Caduet 5MG/10MG tablet bottle label by Physicians Total Care, Inc. Label includes active ingredients amlodipine besylate and atorvastatin calcium. The label specifies 90 tablets per container and indicates caution regarding federal law prohibiting dispensing without prescription. Additional label text includes storage instructions, lot number, and expiration date.*
FDA Label Image

Image Of 5/20 mg Package Label (Package Label 04)

Image Of 5/20 mg Package Label (Package Label 04)
The packaging label for Caduet by Physicians Total Care, Inc. displays the active ingredients amlodipine besylate and atorvastatin calcium with strengths of 5 mg and 20 mg respectively. The label indicates a tablet dosage form with a count of 90 tablets. It includes warnings such as prescription requirement and storage instructions. Additional lot and expiration date details are also present.*
FDA Label Image

Image Of 5/40 mg Package Label (Package Label 05)

Image Of 5/40 mg Package Label (Package Label 05)
The packaging label for Caduet 5/40 mg displays distribution by Physicians Total Care, Inc., Tulsa, OK. It includes the NDC number 54860-5179-0, lot number 0000, and an expiration date of 01/60. The label notes manufacturing by Pfizer Ireland Pharmaceuticals in Dublin, Ireland, and shows a barcode with the number 51790300000.*
FDA Label Image

Image Of 5/80 mg Package Label (Package Label 06)

Image Of 5/80 mg Package Label (Package Label 06)
Label for Caduet 5/80 mg distributed by Physicians Total Care, Inc., Tulsa, OK. The label includes an NDC number, lot number 0000, and expiration date 01/60, along with a barcode.*
FDA Label Image

Image Of 10/10 mg Package Label (Package Label 07)

Image Of 10/10 mg Package Label (Package Label 07)
Label for Caduet 10 mg distributed by Physicians Total Care, Inc. in Tulsa, OK. The label includes the lot number, expiration date (01/60), and a barcode. Manufactured by Pfizer Ireland Pharmaceuticals in Dublin, Ireland.*
FDA Label Image

Image Of 10/20 mg Package Label (Package Label 08)

Image Of 10/20 mg Package Label (Package Label 08)
Packaging label for Caduet, containing amlodipine besylate and atorvastatin calcium, with a strength of 10 mg/20 mg per tablet. The label indicates a package size of 90 tablets and is labeled by Physicians Total Care, Inc. Additional information on the label includes lot number, expiration date, and storage instructions.*
FDA Label Image

Image Of 10/40 mg Package Label (Package Label 09)

Image Of 10/40 mg Package Label (Package Label 09)
Caduet 10 mg/40 mg tablet bottle label from Physicians Total Care, Inc. The label includes active ingredients amlodipine besylate and atorvastatin calcium, with a count of 90 tablets. It contains usage cautions, storage instructions, and lot/expiration details.*
FDA Label Image

Image Of 10/80 mg Package Label (Package Label 10)

Image Of 10/80 mg Package Label (Package Label 10)
Caduet 10 mg / 80 mg tablet bottle label by Physicians Total Care, Inc. The label provides strength information (Amlodipine Besylate / Atorvastatin Calcium), package count (90 tablets), lot number, expiration date, barcode, usage caution, and storage instructions. Label includes federal law warning about prescription requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.